Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy
Clinical trial NCT06089967 · COMPLETED
Trial details
- NCT number
- NCT06089967
- Sponsor
- Duke University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-05
- Primary completion
- 2024-12-06
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.